Ascendia

  MARKET NEWS

Thermo Fisher Scientific Launches Invitrogen TaqMan Cells-to-CT HepatoExpress Kit to Simplify Liver Cell Gene Expression & Help Advance Early Stage Drug Discovery
Minovia Therapeutics Announces Two New US Patents Granted, Strengthening its Mitochondrial Augmentation Therapy Platform
Cellistic Launches Three New iPSC-Based GMP Manufacturing Platforms to Advance Immuno-Oncology & Regenerative Cell Therapies
Bionpharma Receives FDA Approval for Etravirine Tablets Developed in Collaboration With STEERLife
Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands; Announces IND Amendment Clearance Obtained for Clinical Manufacturing of  Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials
Bio-Sourcing & Zerion Pharma Join Forces to Develop First HER2 Oral Monoclonal Antibody Against Breast Cancer
Codexis Expands Reach of Manufacturing Platform Through Evaluation Agreement With Axolabs for Oligonucleotide Therapeutics 
Plus Therapeutics Announces Read Out of Type B Meeting With FDA With Goal of Accelerating Approval of REYOBIQ for Leptomeningeal Metastases
ProMed Pharma Announces Agreement With Undisclosed Partner for Dedicated Manufacturing Suite at New Niagara Ln Facility

  EXPERT CONTENT & RESOURCES

Operational Excellence at Scale: Why Integrated Manufacturing is the Future Biopharmaceutical Standard

Operational Excellence at Scale: Why Integrated Manufacturing is the Future Biopharmaceutical Standard

Pierre Catignol explains how the conventional model creates friction when the industry needs fluidity, and integrated manufacturing answers that call by converting logistical complexity into a reliable operating rhythm that clients trust.

Enabling a Breakthrough in Ophthalmology: A Case Study in Collaboration Between a Biotech & Device Manufacturer on a Novel Drug Delivery System

Enabling a Breakthrough in Ophthalmology: A Case Study in Collaboration Between a Biotech & Device Manufacturer on a Novel Drug Delivery System

Ashwin Agarwal, CFO of Azura Ophthalmics and John Merhige, Co-CEO of Credence MedSystems, share an inside look at how two partners are aligning technical and regulatory strategies, integrating complementary expertise, and collaborating effectively to deliver an innovative ophthalmic combination product and inform future biotech–device partnerships.

The AI-Driven Path to Precision Therapeutics

The AI-Driven Path to Precision Therapeutics

Drs. Rotem Gura-Sadovsky and Maayan Eilon-Ashkenazy explore the potential for AI to transform drug discovery, charting a path towards more targeted precision therapeutics.

  FEATURED EDITORIAL

  COMPANY PROFILE

ABITEC develops and manufactures lipid-based excipients to enhance the bioavailability of poorly water-soluble and poorly permeable Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry. And now with the addition of Larodan, ABITEC has expanded its offerings to include high-purity research grade lipids. ABITEC is now offering Lipids for LNP Therapeutics.  With a catalogue of over 3000 lipid chemistries and the ability to customize and manufacture GMP lipids at both research and manufacturing scale, ABITEC is your partner of choice for customized functional lipids for the formulation of advanced drug delivery platforms, such as lipid nanoparticles. Click here for more.

  WHITEPAPERS & WEBINARS

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

In this talk we illustrate several case studies demonstrating how a fundamental understanding of molecular properties combined with a strategic vision for drug product design can lead to effective and advanceable formulations for even the most challenging drug products.

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

Watch this on-demand webinar to learn about the key steps and considerations in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages. Drawing from our 20 years of experience in the CDMO space, we cover critical topics unique to nanomaterials…..

  WHITEPAPERS & WEBINARS

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

By: Jasmine Musakhanian, Senior Scientific Director, Gattefossé

INTRODUCTION

Mono and diglycerides, also known as partial glycerides, are versatile lipid excipients that play a pivotal role in the realization of drug products and nutraceuticals. Some well-known excipients in this category are …

WHITEPAPER - Manufacturing of 10-mg Loratadine Self-Emulsifying Drug Delivery System (SEDDS) Tablets by Direct Compression With ABISORB-DC & ABISOL Emulsion Preconcentrate Kit

WHITEPAPER - Manufacturing of 10-mg Loratadine Self-Emulsifying Drug Delivery System (SEDDS) Tablets by Direct Compression With ABISORB-DC & ABISOL Emulsion Preconcentrate Kit

Traditionally, lipid-based drug delivery, including SEDDS, for per-oral dosing have primarily been formulated as soft-gels or liquid-filled hard-gels. With ABISORB-DC, the bioavailability enhancing features of lipid-based drug delivery can be combined with the high-throughput and ease of manufacturing of direct …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

January 21 – Drug Delivery
January 28 – Bioavailability